| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |